3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
7
Triple Negative Breast Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasm Metastasis
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Head and Neck Neoplasms
1
GastroEsophageal Cancer
1
Gallbladder Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
CLDN18.2 Positive
1
Anal Cancer Metastatic
1
Adenocarcinoma
1
Interventions
cabozantinib
4
Surveys and Questionnaires
2
Nivolumab
2
Ipilimumab
2
Axitinib
2
zimberelimab
1
temsirolimus
1
salicylhydroxamic acid
1
orellanine
1
brodalumab
1
belzutifan
1
atezolizumab
1
Selenomethionine
1
Ropivacaine
1
Radionuclide Imaging
1
Pluvicto
1
Patient Reported Outcome Measures
1
Methods
1
Magnetic Resonance Imaging
1
Health Promotion
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Everolimus
1
Erlotinib Hydrochloride
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Dacarbazine
1
Counseling
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Albumin-Bound Paclitaxel
×
30 days
×
Clear all
No trials found.